India has emerged as one of the fastest-growing medical device markets in the world, attracting manufacturers from across the globe. However, foreign manufacturers intending to market their medical devices in India cannot directly interact with regulatory authorities for licensing and compliance. Instead, they are required to appoint an Authorized Indian Representative (AIR) who acts as their legal representative before the Central Drugs Standard Control Organization (CDSCO).
The appointment of an AIR is not merely an administrative formality; it is a statutory requirement under the Medical Devices Rules, 2017 (MDR 2017), framed under the Drugs and Cosmetics Act, 1940. The AIR serves as the primary regulatory contact for the CDSCO and is responsible for ensuring that imported medical devices comply with Indian regulatory requirements throughout their lifecycle.
This article explains the legal framework, eligibility criteria, and key responsibilities of an Authorized Indian Representative in India.
What is an Authorized Indian Representative (AIR)?
An Authorized Indian Representative (AIR) is an entity established in India that has been formally authorized by a foreign medical device manufacturer to act on its behalf for regulatory matters related to importing, registering, licensing, and post-market compliance of medical devices in India.
The AIR acts as an official communication channel between foreign manufacturers and the CDSCO. Because overseas manufacturers do not have a legal establishment in India, the AIR assumes responsibility for regulatory interactions, documentation, compliance management, and various post-market obligations.
Unlike a distributor or importer, whose primary role is commercial, the AIR performs regulatory functions and remains accountable for maintaining compliance with the Medical Devices Rules, 2017.
Legal Basis Under the Medical Devices Rules, 2017
The requirement to appoint an Authorized Indian Representative is established under the Medical Devices Rules, 2017, administered by the CDSCO under the Ministry of Health and Family Welfare.
For imported medical devices, applications for import licences are submitted through the CDSCO online portal by the Authorized Indian Representative. The AIR is recognized by the CDSCO as the legally authorized point of contact for regulatory communications, submission of applications, responses to regulatory queries, amendments to licences, and post-approval compliance activities.
Authorization is generally provided through a valid Power of Attorney or Letter of Authorization executed by the foreign manufacturer, empowering the AIR to perform regulatory activities on its behalf.
Who Can Act as an Authorized Indian Representative?
An AIR must be a legal entity established in India and authorized by an overseas manufacturer. Depending on the business arrangement, the following entities may act as an AIR:
The appointed AIR should possess adequate knowledge of Indian medical device regulations, CDSCO procedures, documentation requirements, quality management systems and post-market compliance obligations.
Choosing an experienced AIR is particularly important because regulatory errors, incomplete submissions, or delayed responses may lead to application deficiencies, licence delays, import restrictions, or regulatory actions.
Why is an AIR Mandatory?
The Government of India requires every foreign manufacturer to designate a local regulatory representative to ensure accountability within the country.
Because the CDSCO cannot directly enforce regulatory obligations against entities located outside India, the AIR functions as the responsible Indian representative for regulatory coordination. This arrangement enables faster communication, effective monitoring of imported medical devices, prompt reporting of safety concerns, and efficient implementation of corrective actions when required.
Moreover, during inspections, audits, document verification, or post-market investigations, the CDSCO communicates primarily with the Authorized Indian Representative, making the AIR an integral part of India's medical device regulatory framework.
The responsibilities of an Authorized Indian Representative extend far beyond obtaining an import licence. Throughout the whole regulatory lifetime of medical devices in India, the AIR is still in charge of assisting international manufacturers.
One of the primary responsibilities of the AIR is to prepare, review, and submit applications for import licences through the CDSCO online portal. The AIR ensures that all required documents, including technical dossiers, quality management system certificates, Free Sale Certificates (where applicable), declarations, and other supporting documents, are complete, accurate, and compliant with the Medical Devices Rules, 2017.
The AIR also responds to clarification requests raised by the CDSCO during the application review process and coordinates with the foreign manufacturer to provide additional information whenever required.
The AIR serves as the official point of contact between the CDSCO and foreign manufacturers. All regulatory notices, deficiency letters, approvals, licence amendments, inspections, and compliance-related communications are typically addressed to the AIR.
Maintaining timely communication with the CDSCO is essential to prevent unnecessary delays in licensing and regulatory approvals.
After an import licence is granted, the AIR must ensure that the imported medical devices continue to comply with all applicable regulatory requirements. This includes monitoring licence validity, supporting licence retention or amendments when required, ensuring compliance with applicable labelling provisions, and coordinating regulatory updates whenever there are changes to manufacturing sites, device specifications, intended use, or quality management systems.
The AIR plays a significant role in post-market surveillance by coordinating with foreign manufacturers, importers, distributors, healthcare professionals, and regulatory authorities regarding the safety and performance of medical devices marketed in India.
If any adverse events, serious incidents, malfunctions, or safety concerns are reported, the AIR is expected to facilitate timely reporting to the appropriate authorities in accordance with applicable Indian regulatory requirements and support investigations, risk assessments, and corrective actions.
When a medical device presents a safety risk or requires corrective action, the AIR coordinates product recalls, field safety corrective actions (FSCAs), customer notifications, and communications with the CDSCO.
The AIR is responsible for maintaining regulatory records, approvals, licences, correspondence, technical documents, complaint records, and other compliance-related documentation as required under applicable regulations. Proper documentation facilitates inspections, audits, and regulatory reviews by the CDSCO.
The significance of choosing qualified AIR is often overlooked by overseas manufacturers. Appointing representatives with little regulatory experience, submitting inadequate documentation, delaying responses to CDSCO inquiries, failing to notify regulatory changes on time, and ignoring post-market compliance obligations are common errors. Licensing delays, regulatory actions, and disruptions in product availability could result from such failures.
An experienced Authorized Indian Representative helps foreign manufacturers navigate India's evolving regulatory framework efficiently, while reducing compliance risks. A knowledgeable AIR not only supports successful import licence approvals but also strengthens long-term regulatory compliance, facilitates timely communication with the CDSCO, and assists in maintaining the continued safety and legal marketing of medical devices in India.
An Authorized Indian Representative is a critical regulatory partner for every foreign medical device manufacturer seeking access to the Indian market. From import licence applications and regulatory submissions to vigilance reporting, product recalls, documentation, and ongoing compliance, the AIR performs a wide range of statutory responsibilities under the Medical Devices Rules, 2017. Selecting a qualified and experienced AIR enables manufacturers to meet Indian regulatory requirements more effectively, minimize compliance risks, and ensure uninterrupted market access while maintaining patient safety and regulatory assurance.
Last Updated : 06 Aug 2026
The Brand That Promises To Turn Your Business Around!